CTCL Vaccines

Article

Paris - One of the most promising areas of research for treatment of cutaneous T-cell lymphoma is the development of therapeutic vaccines, according to Wolfram Sterry, M.D., who presented an overview of vaccination therapies for treatment of CTCL here at the World Congress of Dermatology.

Related Videos
Related Content

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

October 3rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Discovering Last Month's Psoriasis Spotlight

October 3rd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

October 3rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Discovering Last Month's Psoriasis Spotlight

October 3rd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

October 3rd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

October 3rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Discovering Last Month's Psoriasis Spotlight

October 3rd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.